Skip to main content

Table 4 Clinical outcome measures pre- vs. post-intervention (group analyses - N = 10)

From: Can kinematic parameters of 3D reach-to-target movements be used as a proxy for clinical outcome measures in chronic stroke rehabilitation? An exploratory study

Outcome

Pre-intervention

Post-intervention

Cohen’s d

Median [Q1; Q3]

Mean ± SD

Median [Q1; Q3]

Mean ± SD

FMA-UEa (points)

32.00 [22.50; 41.50]

32.20 ± 9.60

42.50 [31.75; 48.50]

39.50 ± 10.01

0.76*

WMFT-Timeb (s)

18.03 [14.81; 56.00]

32.82 ± 25.33

14.18 [8.08; 35.30]

24.04 ± 23.54

0.35*

WMFT-FASc (points)

2.77 [1.90; 2.82]

2.39 ± 0.64

3.17 [1.97; 3.51]

2.83 ± 0.77

0.71*

MAL-AOUd (points)

1.01 [0.52; 1.93]

1.19 ± 0.73

1.9 [1.32; 2.61]

2.01 ± 0.86

1.12*

MAL-QOMe (points)

0.99 [0.62; 1.93]

1.21 ± 0.64

1.99 [1.42; 2.65]

2.05 ± 0.78

1.31*

  1. aPoints out of 66. Higher scores indicate reduction of impairments;
  2. bAverage time required to perform the tasks in seconds. Lower scores indicate improved task completion
  3. cPoints out of 5. Higher scores indicate improvement in quality of movement
  4. dPoints out of 5. Higher scores indicate improved perceived usage of UE
  5. ePoints out of 5. Higher scores indicate improved perceived quality of UE use
  6. * Bootstrapped test significant (p < 0.01) after Holm-adjustment
  7. Cohen’s d effect size: d > 0.30 (small), d > 0.50 (medium) and d > 0.80 (large)